REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 63 filers reported holding REPARE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $96,254 | +0.9% | 7,968 | -11.6% | 0.00% | – |
| Q2 2023 | $95,410 | -44.4% | 9,018 | -48.3% | 0.00% | – |
| Q1 2023 | $171,747 | -95.5% | 17,454 | -93.3% | 0.00% | – |
| Q4 2022 | $3,837,633 | +2328.9% | 260,886 | +1913.0% | 0.00% | – |
| Q3 2022 | $158,000 | +0.6% | 12,960 | +15.8% | 0.00% | – |
| Q2 2022 | $157,000 | -65.0% | 11,190 | -64.4% | 0.00% | – |
| Q1 2022 | $448,000 | -33.3% | 31,421 | -1.4% | 0.00% | – |
| Q4 2021 | $672,000 | +9.3% | 31,873 | +36.1% | 0.00% | – |
| Q3 2021 | $615,000 | +307.3% | 23,414 | +383.4% | 0.00% | – |
| Q2 2021 | $151,000 | -75.7% | 4,844 | -76.1% | 0.00% | – |
| Q1 2021 | $622,000 | +1843.8% | 20,295 | +2061.3% | 0.00% | – |
| Q4 2020 | $32,000 | – | 939 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,646,657 | $31,971,617 | 17.00% |
| MPM ASSET MANAGEMENT LLC | 2,242,636 | $27,091,043 | 14.51% |
| CHI Advisors LLC | 2,966,674 | $35,837,422 | 14.20% |
| MPM BioImpact LLC | 1,639,849 | $19,809,376 | 5.29% |
| BVF INC/IL | 8,291,988 | $100,167,215 | 2.70% |
| Deep Track Capital, LP | 3,067,731 | $37,058,190 | 1.43% |
| Redmile Group, LLC | 2,404,695 | $29,048,716 | 1.38% |
| HighVista Strategies LLC | 165,173 | $1,995,290 | 0.92% |
| Orbimed Advisors | 3,322,488 | $40,135,655 | 0.85% |
| Logos Global Management LP | 500,000 | $6,040,000 | 0.81% |